HL7 Clinical Decision Support Systems - CDSS
HL7 Electronic Clinical Decision Support Systems Page
HL7 CDSS Resources
Arden Syntax Workshops, February 2004 (Sydney & Melbourne)
Please Click 'Like' and 'Follow' to Stay-in-Touch with the latest CDSS Developments:
Electronic Clinical Decision Support Technical Workshop December 2003
HL7 Australia, in conjunction with HL7 New Zealand, held a two-day Technical Workshop on Electronic Clinical Decision Support on December 11&12, 2003 (La Trobe University City Campus, 215 Franklin St., Melbourne, Australia). This workshop was an initiative of the HL7 Australia / HL7 New Zealand Electronic Clinical Decision Support Technical Committee. The Technical Workshop was sponsored by HL7 Australia, HL7 New Zealand , the Australian Department of Health and Aging , the New Zealand Ministry of Health , the Australian Quality and Safety Council (ACSQHC) and the Australian National Prescribing Service (NPS) .
The primary focus of the Technical Workshop was on therapeutic information resources, but diagnostics (pathology & radiology) and preventative (immunization) resources were also considered.
Initially, this workshop was proposed as part of an ITOL Grant Application submitted by HL7 Australia to the Australian National Office of Information Economy (NOIE). However, there was general agreement that the Technical Workshop should proceed prior to the outcome of the NOIE grant application. This approach also allowed the involvement of a number of organisations / companies who were unable to participate in the original application to NOIE, including those in New Zealand.
Please 'Share' this with anyone that may be interested:
The outcomes from the Technical Workshop include:
A Draft Report of the Technical Workshop is available.
Our thanks go to the Dept. of Health and Ageing and LaTrobe University for supporting the Workshop.
Arden Syntax Workshop
Our thanks go to the University of Melbourne and Central Queensland University for supporting the Workshop.
Additional Documents and Presentations
HL7 Australia EDS Refined Workplan (presented to Austr. Health Information Council EDS SC, 25 June 2004)
Ken Harvey abstract - 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington, Oct. 2004)
Latest News: HL7Professional Health Speciality Centres Offering Relief to Muscle and Body Pain
Friday, 21st July 2017
Nowadays, it is just not enough to get yourself insured for health or have contacts of expert doctors and physicians to stay in shape. To enjoy a fit body and lead a healthy life, it is necessary that you keep the muscles and body parts free of pain. However, owing to many reasons men and women from various age groups get subjected to various types of pain owing to accidents, lifestyle factors, genetic disorders etc.
Enterprise Mobile Apps For the Healthcare Industry
Thursday, 13th July 2017
The main objective of developing enterprise mobile apps is to acquire a more convenient mode of operation. Typically, healthcare representatives can be seen lugging around tonnes of paperwork with them all the time. However, with an online information repository that is accessible on a mobile or a tablet device, there is no more need for the grunt work. Healthcare enterprise mobile solutions are an awesome way to add convenience to your operations. And this helps not only the hospital staff but also the sales representatives. With all the information available on their mobile and tablet devices, they can go around visiting so many potential clients and deliver a plethora of information to develop new sales.
Concierge Medicine + TeleMedicine = Way To Go!
Tuesday, 11th July 2017
More and more doctors are considering adding telemedicine and concierge medicine business models to increase revenue streams and improve patient services. Many are finding that educating patients about the benefits of telemedicine as a cost-effective, hassle-free care delivery model is the best approach to increasing adoption rates. Armed with smartphones, patients can schedule a same day appointment for both minor and major conditions.
Japanese Pharmaceutical Industry: An Insight Into Globalization
Thursday, 6th July 2017
Japan is the second largest market for pharmaceuticals, with the US being the largest. It represents almost 10% of the world pharmaceutical market. One of the major driving force behind this large market size is the aging of Japanese population i.e. 26% of the Japanese population is 65 years or older. Keeping a higher life expectancy, Japan tops the world list both in male and female population. Consequently, the medical needs are at a surge; thus, boosting the number of pharmaceutical companies, importers, and exporters in Japan.
Could not find the News you were looking for? Search here: